SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research ...
Mesenchymal stromal cells (MSCs) offer significant potential for treating a wide range of human musculoskeletal disorders, encompassing conditions such as cartilage defects, osteoarthritis, ...
Biology software developer Phylo Inc. today announced that it has raised $13.5 million in seed funding. Andreessen Horowitz led the round with Anthology Fund, a $100 million investment vehicle created ...
The Synthetic Biology Market represents one of the fastest-evolving intersections between biotechnology, engineering, and data science, enabling scientists to design and construct new biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results